RNTX short interest
Rein Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 651,179 |
|---|---|
| Change vs prior report | -19,569 (-2.9%) |
| Change over six months | +33.7% |
| Days to cover | 2.35 (sector: 3.78) |
| Average daily volume | 277,566 |
| Rank in Healthcare | #688 of 922 by days to cover |
RNTX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 651,179 | -2.9% | 2.35 | 277,566 |
| 2026-09-15 | 670,748 | +4.3% | 1.41 | 475,577 |
| 2026-08-31 | 642,979 | -12.6% | 1.19 | 542,548 |
| 2026-08-14 | 735,370 | -16.0% | 2.20 | 334,873 |
| 2026-07-31 | 875,037 | -0.4% | 1.93 | 453,565 |
| 2026-07-15 | 878,618 | -2.2% | 2.51 | 350,380 |
| 2026-06-30 | 898,096 | +187.6% | 1.12 | 804,191 |
| 2026-06-15 | 312,225 | -19.4% | 1.00 | 497,880 |
| 2026-05-29 | 387,486 | -8.7% | 1.00 | 489,244 |
| 2026-05-15 | 424,338 | -49.2% | 1.00 | 2,261,318 |
| 2026-04-30 | 835,368 | +252.9% | 3.83 | 217,885 |
| 2026-04-15 | 236,711 | -51.4% | 1.41 | 168,475 |
| 2026-03-31 | 487,162 | +9.2% | 5.37 | 90,710 |
| 2026-03-13 | 446,104 | -0.3% | 5.07 | 88,035 |
| 2026-02-27 | 447,272 | +2.2% | 4.73 | 94,655 |
| 2026-02-13 | 437,424 | -0.8% | 5.58 | 78,407 |
| 2026-01-30 | 441,027 | +25.5% | 3.15 | 140,201 |
| 2026-01-15 | 351,493 | +76.0% | 2.68 | 131,187 |
| 2025-12-31 | 199,688 | -52.5% | 1.00 | 267,208 |
| 2025-12-15 | 420,743 | -1.2% | 1.89 | 222,673 |
| 2025-11-28 | 425,935 | -11.2% | 2.28 | 186,941 |
| 2025-11-14 | 479,607 | +657.5% | 1.00 | 4,969,674 |
| 2025-10-31 | 63,312 | +142.8% | 1.00 | 184,606 |
| 2025-10-15 | 26,079 | +60.5% | 1.00 | 119,938 |
| 2025-09-30 | 16,252 | -23.8% | 1.00 | 331,515 |
import finzdata as yf
yf.Ticker("RNTX").short_interest # every report since 2017
yf.Client().short_interest(["RNTX"], start="2018-01-01")Healthcare short interest · RNTX price history · Who owns RNTX · All short interest